Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study.

Lux MP, Emons J, Bani MR, Wunderle M, Sell C, Preuss C, Rauh C, Jud SM, Heindl F, Langemann H, Geyer T, Brandl AL, Hack CC, Adler W, Schulz-Wendtland R, Beckmann MW, Fasching PA, Gass P.

Breast Care (Basel). 2019 Mar;14(1):41-47. doi: 10.1159/000495883. Epub 2019 Jan 30.

PMID:
31019442
2.

Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer.

Fasching PA, Gass P, Häberle L, Volz B, Hein A, Hack CC, Lux MP, Jud SM, Hartmann A, Beckmann MW, Slamon DJ, Erber R.

Breast Cancer Res Treat. 2019 Jun;175(3):617-625. doi: 10.1007/s10549-019-05198-9. Epub 2019 Mar 13.

PMID:
30868391
3.

Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.

Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fiessler C, Hein A, Häberle L, Jud SM, Lux MP, Janni W, Loehberg CR, Hartkopf AD, Walter CB, Baake G, Fridman A, Malter W, Wuerstlein R, Harbeck N, Hoffmann O, Kümmel S, Martin B, Thomssen C, Graf H, Wolf C, Bayer CM, Hack CC, Almstedt K, Gass P, Heindl F, Brodkorb TF, Nabieva N, Lindner C, Kolberg HC, Krabisch P, Weigel M, Steinfeld-Birg D, Kohls A, Brucker C, Schulz V, Fischer G, Pelzer V, Wallwiener D, Rack B, Fehm T, Rody A, Maass N, Beckmann MW, Fasching PA, Rauh C.

Breast Cancer Res Treat. 2019 Apr;174(2):453-461. doi: 10.1007/s10549-018-05115-6. Epub 2019 Jan 2.

PMID:
30603996
4.

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians.

Gass P, Untch M, Müller V, Möbus V, Thomssen C, Häberle L, Erber R, Hein A, Jud SM, Lux MP, Hack CC, Hartmann A, Kolberg HC, Ettl J, Lüftner D, Jackisch C, Beckmann MW, Janni W, Schneeweiss A, Fasching PA, Nabieva N.

Geburtshilfe Frauenheilkd. 2018 Jul;78(7):707-714. doi: 10.1055/a-0642-9462. Epub 2018 Jul 25.

5.

Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.

Wunderle M, Olmes G, Nabieva N, Häberle L, Jud SM, Hein A, Rauh C, Hack CC, Erber R, Ekici AB, Hoyer J, Vasileiou G, Kraus C, Reis A, Hartmann A, Schulz-Wendtland R, Lux MP, Beckmann MW, Fasching PA.

Geburtshilfe Frauenheilkd. 2018 May;78(5):481-492. doi: 10.1055/a-0603-4350. Epub 2018 Jun 4.

6.

BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.

Wunderle M, Gass P, Häberle L, Flesch VM, Rauh C, Bani MR, Hack CC, Schrauder MG, Jud SM, Emons J, Erber R, Ekici AB, Hoyer J, Vasileiou G, Kraus C, Reis A, Hartmann A, Lux MP, Beckmann MW, Fasching PA, Hein A.

Breast Cancer Res Treat. 2018 Aug;171(1):85-94. doi: 10.1007/s10549-018-4797-8. Epub 2018 May 3.

PMID:
29725888
7.

Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probe.

Emons J, Wunderle M, Hartmann A, Radicke M, Rauh C, Uder M, Gass P, Fasching PA, Langemann H, Beckmann MW, Schulz-Wendtland R, Jud SM.

Acta Radiol. 2018 Dec;59(12):1406-1413. doi: 10.1177/0284185118762249. Epub 2018 Mar 2.

PMID:
29498297
8.

Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound.

Häberle L, Hack CC, Heusinger K, Wagner F, Jud SM, Uder M, Beckmann MW, Schulz-Wendtland R, Wittenberg T, Fasching PA.

Eur J Med Res. 2017 Aug 30;22(1):30. doi: 10.1186/s40001-017-0270-0.

9.

Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers.

Formago M, Schrauder MG, Rauh C, Hack CC, Jud SM, Hildebrandt T, Schulz-Wendtland R, Frentz S, Graubert S, Beckmann MW, Lux MP.

Geburtshilfe Frauenheilkd. 2017 Aug;77(8):879-886. doi: 10.1055/s-0043-114427. Epub 2017 Aug 24.

10.

Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.

Hack CC, Emons J, Jud SM, Heusinger K, Adler W, Gass P, Haeberle L, Heindl F, Hein A, Schulz-Wendtland R, Uder M, Hartmann A, Beckmann MW, Fasching PA, Pöhls UG.

Breast Cancer Res Treat. 2017 Dec;166(3):701-708. doi: 10.1007/s10549-017-4446-7. Epub 2017 Aug 21.

PMID:
28828694
11.

A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First Results.

Schulz-Wendtland R, Jud SM, Fasching PA, Hartmann A, Radicke M, Rauh C, Uder M, Wunderle M, Gass P, Langemann H, Beckmann MW, Emons J.

Geburtshilfe Frauenheilkd. 2017 Jun;77(6):679-685. doi: 10.1055/s-0043-107034. Epub 2017 Apr 27.

12.

Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey.

Klein E, Beckmann MW, Bader W, Brucker C, Dobos G, Fischer D, Hanf V, Hasenburg A, Jud SM, Kalder M, Kiechle M, Kümmel S, Müller A, Müller MT, Paepke D, Rotmann AR, Schütz F, Scharl A, Voiss P, Wallwiener M, Witt C, Hack CC.

Arch Gynecol Obstet. 2017 Aug;296(2):295-301. doi: 10.1007/s00404-017-4420-y. Epub 2017 Jun 8.

13.

Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.

Hack CC, Stoll MJ, Jud SM, Heusinger K, Adler W, Haeberle L, Ganslandt T, Heindl F, Schulz-Wendtland R, Cavallaro A, Uder M, Beckmann MW, Fasching PA, Bayer CM.

Cancer Med. 2017 Jun;6(6):1473-1481. doi: 10.1002/cam4.1066. Epub 2017 May 2.

14.

Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy.

Schulz-Wendtland R, Dankerl P, Bani MR, Fasching PA, Heusinger K, Lux MP, Jud SM, Rauh C, Bayer CM, Schrauder MG, Beckmann MW, Uder M, Brehm B, Loehberg CR.

Geburtshilfe Frauenheilkd. 2017 Feb;77(2):169-175. doi: 10.1055/s-0042-124191.

15.

The PI3K Pathway: Background and Treatment Approaches.

Lux MP, Fasching PA, Schrauder MG, Hein A, Jud SM, Rauh C, Beckmann MW.

Breast Care (Basel). 2016 Dec;11(6):398-404. doi: 10.1159/000453133. Epub 2016 Dec 8. Review.

16.

Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography.

Häberle L, Fasching PA, Brehm B, Heusinger K, Jud SM, Loehberg CR, Hack CC, Preuss C, Lux MP, Hartmann A, Vachon CM, Meier-Meitinger M, Uder M, Beckmann MW, Schulz-Wendtland R.

Int J Cancer. 2016 Nov 1;139(9):1967-74. doi: 10.1002/ijc.30261. Epub 2016 Jul 19.

17.

Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with Anthracycline.

Almstedt K, Fasching PA, Scharl A, Rauh C, Rack B, Hein A, Hack CC, Bayer CM, Jud SM, Schrauder MG, Beckmann MW, Lux MP.

Anticancer Res. 2016 Jan;36(1):419-25.

PMID:
26722076
18.

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases.

Lux MP, Hildebrandt T, Knetzger SM, Schrauder MG, Jud SM, Hein A, Rauh C, Fasching PA, Beckmann MW, Thiel FC.

BMC Cancer. 2015 Aug 14;15:587. doi: 10.1186/s12885-015-1584-3.

19.

Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures.

Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, Kraft P, Hazra A, Li J, Eriksson L, Czene K, Hall P, Jensen M, Cunningham J, Olson JE, Purrington K, Couch FJ, Brown J, Leyland J, Warren RM, Luben RN, Khaw KT, Smith P, Wareham NJ, Jud SM, Heusinger K, Beckmann MW, Douglas JA, Shah KP, Chan HP, Helvie MA, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman C, Giles GG, Baglietto L, Krishnan K, Southey MC, Apicella C, Andrulis IL, Knight JA, Ursin G, Alnaes GI, Kristensen VN, Borresen-Dale AL, Gram IT, Bolla MK, Wang Q, Michailidou K, Dennis J, Simard J, Pharoah P, Dunning AM, Easton DF, Fasching PA, Pankratz VS, Hopper JL, Vachon CM.

Cancer Res. 2015 Jun 15;75(12):2457-67. doi: 10.1158/0008-5472.CAN-14-2012. Epub 2015 Apr 10.

20.

The contributions of breast density and common genetic variation to breast cancer risk.

Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ.

J Natl Cancer Inst. 2015 Mar 4;107(5). pii: dju397. doi: 10.1093/jnci/dju397. Print 2015 May.

21.

Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker Clips.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Wachter DL, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2015 Jan;75(1):72-76.

22.

Association of molecular subtypes with breast cancer risk factors: a case-only analysis.

Rauh C, Gass P, Heusinger K, Haeberle L, Jud SM, Hein A, Loehberg CR, Lux MP, Wachter DL, Heimrich J, Strehl JD, Haller F, Hartmann A, Schulz-Wendtland R, Fiessler C, Beckmann MW, Fasching PA, Poehls U.

Eur J Cancer Prev. 2015 Nov;24(6):484-90. doi: 10.1097/CEJ.0000000000000111.

PMID:
25494290
23.

Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study.

Lux MP, Sell CS, Fasching PA, Seidl-Ertel J, Bani MR, Schrauder MG, Jud SM, Loehberg CR, Rauh C, Hartmann A, Schulz-Wendtland R, Strnad V, Beckmann MW.

Geburtshilfe Frauenheilkd. 2014 Aug;74(8):743-751.

24.

Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?

Schulz-Wendtland R, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Brehm B, Hammon M, Saake M, Dankerl P, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2013 May;73(5):422-427.

25.

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.

26.

Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer.

Schulz-Wendtland R, Dankerl P, Dilbat G, Bani M, Fasching PA, Heusinger K, Lux MP, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M, Brehm B.

Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1135-1138.

27.

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, Fletcher O, Pinder S, Hanby A, Kohut K, Gorman P, Caneppele M, Peto J, Dos Santos Silva I, Johnson N, Swann R, Dwek M, Perkins KA, Gillett C, Houlston R, Ross G, De Ieso P, Southey MC, Hopper JL, Provenzano E, Apicella C, Wesseling J, Cornelissen S, Keeman R, Fasching PA, Jud SM, Ekici AB, Beckmann MW, Kerin MJ, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Laurent-Puig P, Kerbrat P, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Perez JI, Menéndez P, Benitez J, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Lochmann M, Brauch H, Fischer HP, Ko YD; GENICA Network, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Dörk T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Chenevix-Trench G; KConFab Investigators, Lambrechts D, Weltens C, Van Limbergen E, Hatse S, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Volorio S, Giles GG, Severi G, Baglietto L, McLean CA, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Kristensen V, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devillee P, Tollenaar RA, Seynaeve CM, Kriege M, Figueroa J, Chanock SJ, Sherman ME, Hooning MJ, Hollestelle A, van den Ouweland AM, van Deurzen CH, Li J, Czene K, Humphreys K, Cox A, Cross SS, Reed MW, Shah M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Couch FJ, Hallberg E, González-Neira A, Pita G, Alonso MR, Tessier DC, Vincent D, Bacot F, Bolla MK, Wang Q, Dennis J, Michailidou K, Dunning AM, Hall P, Easton D, Pharoah P, Schmidt MK, Tomlinson I, Garcia-Closas M.

PLoS Genet. 2014 Apr 17;10(4):e1004285. doi: 10.1371/journal.pgen.1004285. eCollection 2014 Apr.

28.

[Future of mammography-based imaging].

Schulz-Wendtland R, Wittenberg T, Michel T, Hartmann A, Beckmann MW, Rauh C, Jud SM, Brehm B, Meier-Meitinger M, Anton G, Uder M, Fasching PA.

Radiologe. 2014 Mar;54(3):217-23. doi: 10.1007/s00117-013-2578-2. German.

PMID:
24570108
29.

Health utilities in gynecological oncology and mastology in Germany.

Hildebrandt T, Thiel FC, Fasching PA, Graf C, Bani MR, Loehberg CR, Schrauder MG, Jud SM, Hack CC, Beckmann MW, Lux MP.

Anticancer Res. 2014 Feb;34(2):829-35.

PMID:
24511019
30.

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.

Fasching PA, Jud SM, Hauschild M, Kümmel S, Schütte M, Warm M, Hanf V, Grab D, Krocker J, Stickeler E, Kreienberg R, Müller T, Kühn T, Wolf C, Kahlert S, Paepke S, Berghorn M, Muth M, Baier M, Wackwitz B, Schulz-Wendtland R, Beckmann MW, Lux MP.

BMC Cancer. 2014 Feb 5;14:66. doi: 10.1186/1471-2407-14-66.

31.

Comprehensive visualization of paresthesia in breast cancer survivors.

Jud SM, Hatko R, Maihöfner C, Bani MR, Schrauder MG, Lux MP, Beckmann MW, Bani G, Eder I, Fasching PA, Loehberg CR, Rauh C, Hein A.

Arch Gynecol Obstet. 2014 Jul;290(1):135-41. doi: 10.1007/s00404-014-3164-1. Epub 2014 Feb 5.

PMID:
24496514
32.

Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE study.

Bayer CM, Bani MR, Schneider M, Dammer U, Raabe E, Haeberle L, Faschingbauer F, Schneeberger S, Renner SP, Fischer D, Schulz-Wendtland R, Fasching PA, Beckmann MW, Jud SM.

Eur J Cancer Prev. 2014 May;23(3):151-7. doi: 10.1097/CEJ.0b013e3283651ccb.

PMID:
24100511
33.

Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008.

Lermann J, Segl P, Jud SM, Beckmann MW, Oppelt P, Thiel FC, Renner SP, Müller A.

Arch Gynecol Obstet. 2014 Feb;289(2):329-35. doi: 10.1007/s00404-013-2982-x. Epub 2013 Aug 3. Review.

PMID:
23912533
34.

Genome-wide association studies identify four ER negative-specific breast cancer risk loci.

Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, Brauch H, Chang-Claude J, Carpenter J, Godwin AK, Nevanlinna H, Giles GG, Cox A, Hopper JL, Bolla MK, Wang Q, Dennis J, Dicks E, Howat WJ, Schoof N, Bojesen SE, Lambrechts D, Broeks A, Andrulis IL, Guénel P, Burwinkel B, Sawyer EJ, Hollestelle A, Fletcher O, Winqvist R, Brenner H, Mannermaa A, Hamann U, Meindl A, Lindblom A, Zheng W, Devillee P, Goldberg MS, Lubinski J, Kristensen V, Swerdlow A, Anton-Culver H, Dörk T, Muir K, Matsuo K, Wu AH, Radice P, Teo SH, Shu XO, Blot W, Kang D, Hartman M, Sangrajrang S, Shen CY, Southey MC, Park DJ, Hammet F, Stone J, Veer LJ, Rutgers EJ, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Peto J, Schrauder MG, Ekici AB, Beckmann MW, Dos Santos Silva I, Johnson N, Warren H, Tomlinson I, Kerin MJ, Miller N, Marme F, Schneeweiss A, Sohn C, Truong T, Laurent-Puig P, Kerbrat P, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Perez JI, Menéndez P, Müller H, Arndt V, Stegmaier C, Lichtner P, Lochmann M, Justenhoven C, Ko YD; Gene ENvironmental Interaction and breast CAncer (GENICA) Network, Muranen TA, Aittomäki K, Blomqvist C, Greco D, Heikkinen T, Ito H, Iwata H, Yatabe Y, Antonenkova NN, Margolin S, Kataja V, Kosma VM, Hartikainen JM, Balleine R; kConFab Investigators, Tseng CC, Berg DV, Stram DO, Neven P, Dieudonné AS, Leunen K, Rudolph A, Nickels S, Flesch-Janys D, Peterlongo P, Peissel B, Bernard L, Olson JE, Wang X, Stevens K, Severi G, Baglietto L, McLean C, Coetzee GA, Feng Y, Henderson BE, Schumacher F, Bogdanova NV, Labrèche F, Dumont M, Yip CH, Taib NA, Cheng CY, Shrubsole M, Long J, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Knight JA, Glendon G, Mulligan AM, Tollenaar RA, Seynaeve CM, Kriege M, Hooning MJ, van den Ouweland AM, van Deurzen CH, Lu W, Gao YT, Cai H, Balasubramanian SP, Cross SS, Reed MW, Signorello L, Cai Q, Shah M, Miao H, Chan CW, Chia KS, Jakubowska A, Jaworska K, Durda K, Hsiung CN, Wu PE, Yu JC, Ashworth A, Jones M, Tessier DC, González-Neira A, Pita G, Alonso MR, Vincent D, Bacot F, Ambrosone CB, Bandera EV, John EM, Chen GK, Hu JJ, Rodriguez-Gil JL, Bernstein L, Press MF, Ziegler RG, Millikan RM, Deming-Halverson SL, Nyante S, Ingles SA, Waisfisz Q, Tsimiklis H, Makalic E, Schmidt D, Bui M, Gibson L, Müller-Myhsok B, Schmutzler RK, Hein R, Dahmen N, Beckmann L, Aaltonen K, Czene K, Irwanto A, Liu J, Turnbull C; Familial Breast Cancer Study (FBCS), Rahman N, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F; Australian Breast Cancer Tissue Bank (ABCTB) Investigators, Olswold C, Slager S, Pilarski R, Ademuyiwa F, Konstantopoulou I, Martin NG, Montgomery GW, Slamon DJ, Rauh C, Lux MP, Jud SM, Bruning T, Weaver J, Sharma P, Pathak H, Tapper W, Gerty S, Durcan L, Trichopoulos D, Tumino R, Peeters PH, Kaaks R, Campa D, Canzian F, Weiderpass E, Johansson M, Khaw KT, Travis R, Clavel-Chapelon F, Kolonel LN, Chen C, Beck A, Hankinson SE, Berg CD, Hoover RN, Lissowska J, Figueroa JD, Chasman DI, Gaudet MM, Diver WR, Willett WC, Hunter DJ, Simard J, Benitez J, Dunning AM, Sherman ME, Chenevix-Trench G, Chanock SJ, Hall P, Pharoah PD, Vachon C, Easton DF, Haiman CA, Kraft P.

Nat Genet. 2013 Apr;45(4):392-8, 398e1-2. doi: 10.1038/ng.2561.

35.

Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.

Loehberg CR, Almstedt K, Jud SM, Haeberle L, Fasching PA, Hack CC, Lux MP, Thiel FC, Schrauder MG, Brunner M, Bayer CM, Hein A, Heusinger K, Heimrich J, Bani MR, Renner SP, Hartmann A, Beckmann MW, Wachter DL.

Breast Cancer Res Treat. 2013 Apr;138(3):899-908. doi: 10.1007/s10549-013-2460-y. Epub 2013 Mar 12.

PMID:
23479421
36.

Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients.

Hack CC, Häberle L, Geisler K, Schulz-Wendtland R, Hartmann A, Fasching PA, Uder M, Wachter DL, Jud SM, Loehberg CR, Lux MP, Rauh C, Beckmann MW, Heusinger K.

Geburtshilfe Frauenheilkd. 2013 Feb;73(2):136-141.

37.

Financing of certified centers: a willingness-to-pay analysis.

Thiel FC, Scharl A, Hildebrandt T, Kotziabassis E, Schrauder MG, Bani MR, Müller A, Hauzenberger T, Loehberg CR, Jud SM, Fasching PA, Hartmann A, Schulz-Wendtland R, Strnad V, Beckmann MW, Lux MP.

Arch Gynecol Obstet. 2013 Mar;287(3):495-509. doi: 10.1007/s00404-012-2572-3. Epub 2012 Oct 19.

PMID:
23080545
38.

Factors influencing breast changes after pregnancy.

Rauh C, Faschingbauer F, Haeberle L, Jud SM, Heusinger K, Fasching PA, Goecke TW, Rajakaruna N, Voigt F, Bani MR, Lux MP, Renner SP, Loehberg CR, Hartmann A, Schulz-Wendtland R, Beckmann MW, Bayer CM.

Eur J Cancer Prev. 2013 May;22(3):259-61. doi: 10.1097/CEJ.0b013e328359cb81.

PMID:
23022745
39.

Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer.

Heusinger K, Jud SM, Häberle L, Hack CC, Fasching PA, Meier-Meitinger M, Lux MP, Hagenbeck C, Loehberg CR, Wittenberg T, Rauh C, Wagner F, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Wachter DL.

Breast Cancer Res Treat. 2012 Oct;135(3):885-92. doi: 10.1007/s10549-012-2221-3. Epub 2012 Aug 31.

PMID:
22936391
40.

Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer.

Rauh C, Hack CC, Häberle L, Hein A, Engel A, Schrauder MG, Fasching PA, Jud SM, Ekici AB, Loehberg CR, Meier-Meitinger M, Ozan S, Schulz-Wendtland R, Uder M, Hartmann A, Wachter DL, Beckmann MW, Heusinger K.

Geburtshilfe Frauenheilkd. 2012 Aug;72(8):727-733.

41.

Hormone replacement therapy and prognosis in ovarian cancer patients.

Hein A, Thiel FC, Bayer CM, Fasching PA, Häberle L, Lux MP, Renner SP, Jud SM, Schrauder MG, Müller A, Wachter D, Strehl J, Hartmann A, Beckmann MW, Rauh C.

Eur J Cancer Prev. 2013 Jan;22(1):52-8. doi: 10.1097/CEJ.0b013e328355ec22.

PMID:
22694828
42.

Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?

Schulz-Wendtland R, Dilbat G, Bani M, Fasching PA, Lux MP, Wenkel E, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2012 Jun;72(6):532-538.

43.

Visual pain mapping in endometriosis.

Renner SP, Boosz AS, Burghaus S, Maihöfner C, Beckmann MW, Fasching PA, Jud SM.

Arch Gynecol Obstet. 2012 Sep;286(3):687-93. doi: 10.1007/s00404-012-2369-4. Epub 2012 May 9.

PMID:
22569716
44.

Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se.

Schulz-Wendtland R, Bani M, Lux MP, Schwab S, Loehberg CR, Jud SM, Rauh C, Bayer CM, Beckmann MW, Uder M, Fasching PA, Adamietz B, Meier-Meitinger M.

Geburtshilfe Frauenheilkd. 2012 May;72(5):408-411.

45.

Characterizing mammographic images by using generic texture features.

Häberle L, Wagner F, Fasching PA, Jud SM, Heusinger K, Loehberg CR, Hein A, Bayer CM, Hack CC, Lux MP, Binder K, Elter M, Münzenmayer C, Schulz-Wendtland R, Meier-Meitinger M, Adamietz BR, Uder M, Beckmann MW, Wittenberg T.

Breast Cancer Res. 2012 Apr 10;14(2):R59.

46.

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk.

Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, Khaw KT, Ursin G, Lee E, Gayther SA, Ramus SJ, Eeles RA, Leach MO, Kwan-Lim G, Couch FJ, Giles GG, Baglietto L, Krishnan K, Southey MC, Le Marchand L, Kolonel LN, Woolcott C, Maskarinec G, Haiman CA, Walker K, Johnson N, McCormack VA, Biong M, Alnaes GI, Gram IT, Kristensen VN, Børresen-Dale AL, Lindström S, Hankinson SE, Hunter DJ, Andrulis IL, Knight JA, Boyd NF, Figuero JD, Lissowska J, Wesolowska E, Peplonska B, Bukowska A, Reszka E, Liu J, Eriksson L, Czene K, Audley T, Wu AH, Pankratz VS, Hopper JL, dos-Santos-Silva I.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1156-66. doi: 10.1158/1055-9965.EPI-12-0066. Epub 2012 Mar 27.

47.

Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study.

Heusinger K, Jud SM, Häberle L, Hack CC, Adamietz BR, Meier-Meitinger M, Lux MP, Wittenberg T, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA.

Int J Cancer. 2012 Dec 1;131(11):2643-9. doi: 10.1002/ijc.27515. Epub 2012 Mar 28.

48.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

49.

Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology.

Lux MP, Fasching PA, Loehberg CR, Jud SM, Schrauder MG, Bani MR, Thiel FC, Hack CC, Hildebrandt T, Beckmann MW.

Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1046-1055. Review.

50.

Breast Cancer Risk - Genes, Environment and Clinics.

Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2011 Dec;71(12):1056-1066.

Supplemental Content

Support Center